Baxter International Inc. (BAX)
NYSE: BAX
· Real-Time Price · USD
30.80
-0.37 (-1.19%)
At close: May 01, 2025, 12:24 PM
-1.19% (1D)
| Bid | 30.77 |
| Market Cap | 15.8B |
| Revenue (ttm) | 12.86B |
| Net Income (ttm) | -649M |
| EPS (ttm) | -0.64 |
| PE Ratio (ttm) | -48.12 |
| Forward PE | 11.43 |
| Analyst | Hold |
| Ask | 30.8 |
| Volume | 3,790,577 |
| Avg. Volume (20D) | 4,988,988 |
| Open | 32.15 |
| Previous Close | 31.17 |
| Day's Range | 30.78 - 32.60 |
| 52-Week Range | 26.25 - 40.49 |
| Beta | 0.65 |
About BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nu...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Oct 27, 1981
Employees 38,000
Stock Exchange NYSE
Ticker Symbol BAX
Website https://www.baxter.com
Analyst Forecast
According to 9 analyst ratings, the average rating for BAX stock is "Hold." The 12-month stock price forecast is $40, which is an increase of 29.89% from the latest price.
Stock ForecastsEarnings Surprise
Baxter International has released their quartely earnings
on May 1, 2025:
Next Earnings Release
Baxter International Inc. is scheduled to release its earnings on May 1, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
Just now
BAX stock has given up its prior gain. Baxter Inte...
Unlock content with
Pro Subscription
2 hours ago
Baxter International shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 adjusted EPS guidance.
